Pillar Biosciences Announces U.S. Food and Drug Administration Acceptance of Premarket Approval (PMA) Supplement Application for Pan-cancer oncoReveal™ CDx  https://t.co/ULEPrqkNNO  https://t.co/xrZZq8Gi6m